ストックスクリーナーアプリを入手
7.65
2.82%
0.21
アフターアワーズ：
7.65
Kura Oncology Inc (KURA) 最新ニュース
Using RSI to spot recovery in Kura Oncology Inc.Exit Point & Fast Gaining Stock Strategy Reports - Newser
Volume spikes in Kura Oncology Inc. stock – what they meanWeekly Market Summary & Free Safe Entry Trade Signal Reports - Newser
Tools to assess Kura Oncology Inc.’s risk profileWeekly Market Outlook & Weekly High Return Stock Opportunities - Newser
What data driven models say about Kura Oncology Inc.’s future2025 Year in Review & Risk Managed Investment Entry Signals - Newser
Published on: 2025-08-19 23:46:42 - Newser
Comparing Kura Oncology Inc. in custom built stock radarsWeekly Investment Recap & Weekly Breakout Stock Alerts - Newser
What does recent volatility data suggest for Kura Oncology Inc.2025 Price Targets & Entry Point Confirmation Alerts - Newser
Why Kura Oncology Inc. is moving todayJuly 2025 Institutional & Weekly High Potential Stock Alerts - Newser
Kura Oncology Inc (KURA Stock: A Sea of Opportunity - investchronicle.com
Kura Oncology Gains 32%, Insider Trades Reap Benefit - simplywall.st
Chart based analysis of Kura Oncology Inc. trendsJuly 2025 Retail & Free High Return Stock Watch Alerts - Newser
Analyzing Kura Oncology Inc. with multi timeframe charts2025 Buyback Activity & Target Return Focused Picks - Newser
What high frequency data says about Kura Oncology Inc.2025 Major Catalysts & Safe Capital Growth Trade Ideas - Newser
Order flow analysis tools used on Kura Oncology Inc.Earnings Risk Summary & Real-Time Volume Analysis Alerts - Newser
Kura Oncology (NASDAQ:KURA) Shares Gap Up – Still a Buy? - Defense World
Is Kura Oncology Inc. stock entering bullish territoryTreasury Yields & Long-Term Growth Plans - Newser
Wall Street Zen Upgrades Kura Oncology (NASDAQ:KURA) to “Hold” - Defense World
Using Bollinger Bands to evaluate Kura Oncology Inc.July 2025 Retail & AI Forecasted Entry and Exit Points - Newser
What makes Kura Oncology Inc. stock price move sharply2025 Macro Impact & Weekly Watchlist for Consistent Profits - Newser
CEO Buy-In and Analyst Optimism at Kura Oncology: A Strategic Opportunity in Oncology Innovation - AInvest
Quant Strategy Flags Kura Oncology Inc. for EntryMarket Performance Recap & Safe Swing Trade Setup Alerts - metal.it
How hedge fund analytics apply to Kura Oncology Inc. stockMarket Trend Report & Verified Stock Trade Ideas - Newser
Kura Oncology Inc. stock chart pattern explainedJuly 2025 Final Week & AI Driven Stock Movement Reports - Newser
Kura Oncology Shares Rise After CEO Buys Company Shares - MarketScreener
Why Kura Oncology (KURA.O) Spiked 14% on a Quiet Day — A Technical Deep Dive - AInvest
Kura Oncology Surges 13.18%—What's Really Behind the Intraday Move? - AInvest
Multi asset correlation models including Kura Oncology Inc.July 2025 Sector Moves & Daily Volume Surge Signals - Newser
US Bancorp DE Acquires 17,523 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Kura Oncology’s CEO Makes a Bold Move with Significant Stock Purchase - TipRanks
Price Consolidation Hints at Upcoming Move in Kura Oncology Inc.2025 Fundamental Recap & Weekly Setup with ROI Potential - 선데이타임즈
JMP Securities Lowers Kura Oncology Price Target to $24, Maintains Market Outperform Rating - AInvest
Analysts Weigh In on 10x Genomics, Kura Oncology and Insulet: Buy or Hold? - AInvest
JMP Securities Has Lowered Expectations for Kura Oncology (NASDAQ:KURA) Stock Price - Defense World
Kura Oncology’s Earnings Call: Progress Amidst Challenges - TipRanks
Kura Oncology, Inc. (NASDAQ:KURA) Q2 2025 Earnings Call Transcript - Insider Monkey
Why Kura Oncology Inc. stock attracts strong analyst attentionDouble in 10 Days Stock Ideas - newsyoung.net
Kura Oncology’s SWOT analysis: ziftomenib’s potential drives stock outlook - Investing.com
Kura Oncology’s SWOT analysis: ziftomenib’s potential drives stock outlook By Investing.com - Investing.com Nigeria
Wedbush Has Bearish Forecast for Kura Oncology Q1 Earnings - Defense World
Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
JMP Securities Maintains Market Outperform on Kura Oncology with New PT of $24 - AInvest
Kura Oncology stock price target lowered to $24 at Citizens JMP - Investing.com Canada
What candlestick patterns are forming on Kura Oncology Inc.Free Pattern Detection for Entry Confirmation - Newser
Kura Oncology price target lowered to $27 from $29 at BofA - TipRanks
Kura Oncology, Inc. (NASDAQ:KURA) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance
Kura Oncology Reports Q2 2025 Earnings: Key Takeaways - AInvest
Candlestick Reversal Detected on Kura Oncology Inc.’s ChartStrong Buy With Technical Confidence Supported - beatles.ru
How to escape a deep drawdown in Kura Oncology Inc.Market Downturn Defense Strategy Analysis - Newser
Kura Oncology shares fall 5.12% intraday despite FDA Priority Review of ziftomenib NDA. - AInvest
Kura Oncology’s Promising Future: Strong Financials and Advancements in AML Treatment Drive Buy Rating - TipRanks
Earnings call transcript: Kura Oncology Q2 2025 shows revenue miss, EPS below forecast By Investing.com - Investing.com South Africa
Earnings call transcript: Kura Oncology Q2 2025 shows revenue miss, EPS below forecast - Investing.com Australia
0.94%
1.72%
大文字化:
|
ボリューム (24 時間):